2024-03-28T21:19:03Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_E083DCF672DB
2024-03-23T03:06:23Z
openaire
documents
urnserval
serval:BIB_E083DCF672DB
A prospective phase I-II trial of the cyclooxygenase-2 inhibitor celecoxib in patients with carcinoma of the cervix with biomarker assessment of the tumor microenvironment.
10.1016/j.ijrobp.2006.08.024
000243292000014
17056201
Herrera
F.G.
author
Chan
P.
author
Doll
C.
author
Milosevic
M.
author
Oza
A.
author
Syed
A.
author
Pintilie
M.
author
Levin
W.
author
Manchul
L.
author
Fyles
A.
author
article
2007-01-01
International journal of radiation oncology, biology, physics
0360-3016
0360-3016
journal
67
1
97-103
Adult
Aged
Biomarkers, Tumor
Celecoxib
Cell Hypoxia/drug effects
Combined Modality Therapy/methods
Cyclooxygenase 2 Inhibitors/adverse effects
Cyclooxygenase 2 Inhibitors/therapeutic use
Double-Blind Method
Extracellular Fluid/physiology
Female
Follow-Up Studies
Gastrointestinal Diseases/chemically induced
Humans
Leukopenia/chemically induced
Middle Aged
Oxygen Consumption
Prospective Studies
Pyrazoles/adverse effects
Pyrazoles/therapeutic use
Rectovaginal Fistula/chemically induced
Remission Induction
Sulfonamides/adverse effects
Sulfonamides/therapeutic use
Uterine Cervical Neoplasms/drug therapy
Uterine Cervical Neoplasms/metabolism
Uterine Cervical Neoplasms/mortality
Uterine Cervical Neoplasms/radiotherapy
eng
60_published
true
peer-reviewed
Publication types: Clinical Trial, Phase I ; Clinical Trial, Phase II ; Journal Article
Publication Status: ppublish
https://serval.unil.ch/notice/serval:BIB_E083DCF672DB
https://serval.unil.ch/resource/serval:BIB_E083DCF672DB.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_E083DCF672DB7
Copying allowed only for non-profit organizations